Kizuta saponin K11 是一种存在于 Kalopanax pictum var. maximowiczii 叶子中的皂苷。Kalopanax pictum var. maximowiczii 是一种韩国药用植物。
Kizuta saponin K11 Chemical Structure
CAS No. : 97240-03-4
规格
是否有货
5 mg
询价
10 mg
询价
25 mg
询价
* Please select Quantity before adding items.
生物活性
Kizuta saponin K11 is a saponin found in the leaves of Kalopanax pictum var. maximowiczii, a Korean medicinal plant[1].
分子量
1263.41
Formula
C61H98O27
CAS 号
97240-03-4
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献
[1]. Hahn DR, et al. Saponins from leaves of Kalopanax pictum var. maximowiczii, a Korean medicinal plant. Chem Pharm Bull (Tokyo). 1989;37(8):2234-2235.
Pulsatilla saponin D;(Synonyms: SB365; Hederacolchiside A) 纯度: 98.47%
Pulsatilla saponin D (SB365) 可从 Pulsatilla koreana Nakai 根部分离得到,具有抗癌活性。
Pulsatilla saponin D Chemical Structure
CAS No. : 68027-15-6
规格
价格
是否有货
数量
10;mM;*;1 mL in DMSO
¥3977
In-stock
5 mg
¥1980
In-stock
10 mg
;
询价
;
50 mg
;
询价
;
* Please select Quantity before adding items.
Pulsatilla saponin D 相关产品
bull;相关化合物库:
Natural Product Library Plus
Bioactive Compound Library Plus
Apoptosis Compound Library
Natural Product Library
Anti-Cancer Compound Library
Glycoside Compound Library
Terpenoids Library
Traditional Chinese Medicine Monomer Library
Anti-Lung Cancer Compound Library
Anti-Pancreatic Cancer Compound Library
生物活性
Pulsatilla saponin D (SB365), isolated from the root of Pulsatilla koreana Nakai, is an anti-tumor agent[1][2][3][4].
体外研究 (In Vitro)
Pulsatilla saponin D (SB365) shows apoptotic effect accompanied by increased evidence of cleaved caspase-3 and poly (ADP ribose) polymerase[1]. Pulsatilla saponin D (SB365) strongly inhibits c-Met expression in gastric cancer cells[1]. Pulsatilla saponin D (SB365) strongly suppresses the growth and proliferation of 5 human pancreatic cancer cell lines (MIAPaCa-2, BXPC-3, PANC-1, AsPC-1 and HPAC) [2]. Pulsatilla saponin D (SB365) shows anti-angiogenic activity by decreasing the expression of HIF-1α and VEGF[3]. Pulsatilla saponin D (0.3 ng/mL to 10 μg/mL) exhibits anti-tumor activity in NSCLC cancer cells[4].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Cytotoxicity Assay[4]
Cell Line:
A-549, SKMEL-2, MCF-7, and Lewis lung carcinoma (LLC) cells.
Concentration:
0.3 ng/mL to 10 μg/mL.
Incubation Time:
72 h.
Result:
Exhibited an ED50 value of 6.3 μg/mL for A-549 cells.
体内研究 (In Vivo)
Pulsatilla saponin D (6.4 mg/kg) exhibits anti-tumor activity in Lewis lung carcinoma model[4].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
2x2x2 mm3 tumor fragments of a Lewis lung carcinoma (LLC) transplanted s.c. into the auxiliary region of the BDF1 mice[4].
Dosage:
6.4 mg/kg.
Administration:
Intraperitoneally on the 1 st to 7 th and 9 th to 14 th day.
Result:
Had such a potent antitumor effect (IR, 82 %) on a solid tumor, which is higher than Adriamycin (IR, 64%).
分子量
913.10
Formula
C47H76O17
CAS 号
68027-15-6
中文名称
白头翁皂苷 D
运输条件
Room temperature in continental US; may vary elsewhere.
[1]. Hong SW, et al. SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis. 2013 Sep;34(9):2156-69.
[2]. Son MK, et al. SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells. Oncol Rep. 2013 Aug;30(2):801-8.
[3]. Son MK, et al. SB365, Pulsatilla saponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT/mTOR signalling pathway. Food Chem. 2013 Jan 1;136(1):26-33.
[4]. Yong Kim, et al. Pulsatilla saponin D: the antitumor principle from Pulsatilla koreana. Arch Pharm Res. 2004 Sep;27(9):915-8.
Paris saponin VII (Chonglou Saponin VII) is a steroidal saponin isolated from the roots and rhizomes of Trillium tschonoskii Maxim. Paris saponin VII-induced apoptosis in K562/ADR cells is associated with Akt/MAPK and the inhibition of P-gp. Paris saponin VII attenuates mitochondrial membrane potential, increases the expression of apoptosis-related proteins, such as Bax and cytochrome c, and decreases the protein expression levels of Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt. Paris saponin VII induces a robust autophagy in K562/ADR cells and provides a biochemical basis in the treatment of leukemia[1].
IC50 Target[1]
Akt
;
p38
;
Bcl-2
;
Caspase-9
;
Caspase-3
;
PARP-1
;
体外研究 (In Vitro)
Paris saponin VII (Chonglou Saponin VII) inhibits the growth of adriamycin-resistant human leukemia cells (K562/ADR) in a dose-dependent manner. Paris saponin VII significantly suppresses cell proliferation by cell cycle arrest in the G0/G1 phase[1].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究 (In Vivo)
Paris saponin VII (Chonglou Saponin VII) (intravenous administration) significantly enhances anticancer efficacy of adriamycin to MCF-7/ADR xenograft model in nude mice[2].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
分子量
1031.18
Formula
C51H82O21
CAS 号
68124-04-9
中文名称
重楼皂苷 VII
运输条件
Room temperature in continental US; may vary elsewhere.
[1]. Yan T, et al. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Phytother Res. 2018 May;32(5):898-907.
[2]. Li Y, et al. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells. J Ethnopharmacol. 2019 Mar 25;232:47-54.